Options for Fertility Preservation in Children

Pediatr Endocrinol Rev. 2018 Mar;15(3):223-233. doi: 10.17458/per.vol15.2018.jkpj.fertilitypreservation.

Abstract

Fertility preservation therapies can conserve future reproductive potential for persons facing serious medical diagnoses. With cure rates for childhood cancer reaching almost 80%, quality-of-life concerns for long-term survivors, including future parenting, are becoming more pertinent. Late effects of childhood cancer can be divided into physical, social, psychological, and spiritual domains. Potential loss of fertility threatens the well-being of these children in all these domains. Providers often hesitate to discuss fertility preservation with the patients. However, parental attitudes toward discussion of fertility preservation have been found to be open to such conversations for both prepubertal and postpubertal children who have a cancer diagnosis. Multiple national and international organizations recommend discussion with all persons having gonadotoxic therapy, including children, regarding the effect of planned treatment on future fertility and their options for fertility preservation. Renal or rheumatologic disease treated with high-dose cyclophosphamide and chromosomal anomalies such as Turner or Klinefelter syndrome may be amenable to fertility preservation. This essay reviews fertility preservation options available to children, as well as the expanding list of indications for fertility preservation.

Keywords: Cancer survivorship; Fertility preservation; Pediatric cancer; Pediatric reproductive health.

MeSH terms

  • Child
  • Fertility
  • Fertility Preservation*
  • Humans
  • Neoplasms*
  • Quality of Life
  • Survivors